F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review, interview, and facility policy review the facility failed to administer rapid-acting insulin in a
timely manner. This affected two Residents (#5 and #6) of 15 residents who required insulin daily. The
facility census was 104.
Residents Affected - Few
Findings include:
1. Review of the medical record for Resident #5 revealed an admission date of 09/11/21. Diagnoses
included type two diabetes mellitus and need for assistance with personal care.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed the resident had
intact cognition.
Review of physician order for Resident #5 revealed an order for 18 units of Humalog solution (paid acting
insulin) (dated 08/04/23) subcutaneously before meals for glucose control. The time of administration
ordered by the physician was 6:30 A.M.
Review of breakfast service revealed Resident #5 was not expected to receive breakfast until 8:20 A.M.
Review of the medication administration records (MAR) for April 2023 revealed Resident #5 received18
units of Humalog insulin at 6:13 A.M. on 04/07/23, 5:50 A.M. on 04/08/23, 5:49 A.M. on 04/11/23, and 5:45
A.M. on 04/14/23.
2. Review of the medical record for Resident #6 revealed an admission date of 03/03/23. Diagnoses
included type two diabetes mellitus with hypo/hyperglycemia.
Review of the quarterly MDS assessment dated [DATE] revealed Resident #6 had intact cognition.
Review of physician order for Resident #6 revealed an order for Humalog solution (dated 03/14/23)
subcutaneously before meals (sliding scale) for glucose control. The time of administration ordered by the
physician was 6:30 A.M.
Review of the MAR for April 2023 revealed Resident #6 received eight units of Humalog at 6:19 A.M. on
04/01/23, six units at 6:36 A.M. on 04/03/23, two units at 6:00 A.M. on 04/07/23, and eight units at 6:22
A.M. on 04/14/23.
Review of breakfast service revealed Resident #6 was not expected to receive breakfast unit 7:50
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365392
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365392
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/14/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Rocky River Gardens Rehab and Nursing Ctr
4102 Rocky River Dr
Cleveland, OH 44135
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
A.M.
Level of Harm - Minimal harm
or potential for actual harm
Interviews on 04/14 23 from 8:08 A.M. to 8:43 A.M., Licensed Practical Nurse (LPN) #204, Registered
Nurse (RN) #205, LPN #206 and LPN #207 stated rapid-acting insulin should be administered 10 to 15
minutes before meals.
Residents Affected - Few
Interviews on 04/14/23 from 10:57 A.M. to 11:03 A.M., Residents #5 and #6 stated they had no adverse
effects from receiving insulin hours before a meal; however, both residents stated that staff had
administered insulin a couple hours before breakfast was served.
Interview on 04/14/23 at 10:40 A.M., LPN #208 verified the administration times for Residents #5 and #6,
and stated the insulin should be given right before meals to prevent low blood sugars.
Interview on 04/14/23 at 11:15 A.M., the Regional Director of Clinical Services (RDCS) #210, Assistant
Director of Nursing (ADON) #211 and Administrator were informed of the concern related to the time of the
insulin administration. RDCS # 210 stated rapid-acting insulins like Humalog should be administered 15-20
minutes before meals are consumed.
Review of the facility policy titled Insulin Administration, dated 2015, revealed limited information indicating
the appropriate time to administer rapid-acting insulin.
This deficiency represents non-compliance investigated under Complaint Number OH00140218.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365392
If continuation sheet
Page 2 of 2